Progress in Nanomaterials-based Electrochemical Biosensors for Beta-amyloid Peptides as the Biomarkers of Alzheimer's Disease

4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Alzheimer's disease (AD) have affected the older population worldwide through the rapid decline in cognitive impairment. Mounting evidence suggest that beta-amyloid peptide (Aβ) and its derivates are closely related to the emergence and growth of AD. Thus, the specific and sensitive detection of Aβ species have an important role in the early diagnosis of AD. Electrochemical method is a promising candidate for bioassays. The current review mainly focuses on the development of nanomaterials-based electrochemical biosensors for Aβ species in the past decades. We cover the comprehensive utilization of nanomaterials in biosensor construction as the electrode substrate and signal reporters.

Cite

CITATION STYLE

APA

Feng, Y. X., & Chen, C. D. (2022). Progress in Nanomaterials-based Electrochemical Biosensors for Beta-amyloid Peptides as the Biomarkers of Alzheimer’s Disease. International Journal of Electrochemical Science, 17. https://doi.org/10.20964/2022.03.43

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free